ClinicalTrials.Veeva

Menu

Effects of a 5-Week Probiotic Supplementation Intervention on Markers of Delayed Onset Muscle Soreness

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Begins enrollment this month

Conditions

Exercise Induced Muscle Damage
Delayed Onset Muscle Soreness (DOMS)

Treatments

Dietary Supplement: Lactobacillus casei
Other: Placebo Capsule(s)

Study type

Interventional

Funder types

Other

Identifiers

NCT07219498
Probiotic Supplementation

Details and patient eligibility

About

The purpose of this study is to evaluate how probiotic supplementation (PS) influences post-exercise recovery in healthy, physically active young adults. Researchers aim to determine if the Lactobacillus casei probiotic strain reduces symptoms of delayed onset muscle soreness (DOMS) based on perceived muscle soreness, pressure pain threshold, and power output following exercise induced muscle damage (EIMD).

Enrollment

24 estimated patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • complete a minimum of 150 minutes a week of at least moderate intensity exercise in either an endurance-based or resistance-based training style based on a self-reported physical activity over the past month
  • good general health with no injuries or health conditions that would affect physical activity
  • willing to abstain from consistent NSAID use and other probiotic supplements over the course of this study

Exclusion criteria

  • known musculoskeletal injuries or physical limitations that could interfere with performing the designated physical activity required
  • underlying conditions that could place them at an increased risk during exercise such as cardiovascular, respiratory, or metabolic diseases
  • currently take a probiotic supplement, are prescribed and taking an antibiotic during the intervention, or report using NSAIDs or steroids within the recovery time window
  • report using an NSAID more than twice a week on a regular basis

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

24 participants in 2 patient groups, including a placebo group

Probiotic Group
Active Comparator group
Treatment:
Dietary Supplement: Lactobacillus casei
Placebo Group
Placebo Comparator group
Treatment:
Other: Placebo Capsule(s)

Trial contacts and locations

1

Loading...

Central trial contact

Jakob Fischer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems